3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
11
Nasopharyngeal Carcinoma
4
Thyroid Neoplasms
3
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Melanoma
3
Endometrial Neoplasms
3
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoid Interstitial Pneumonia
2
Lung Neoplasms
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Breast Neoplasms
2
Urologic Neoplasms
1
Tongue Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomach Neoplasms
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Nivolumab
2
Biopsy
2
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
ceralasertib
1
belinostat
1
X-Rays
1
Ipilimumab
1
Immunoglobulin G
1
Fluorouracil
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Immunoglobulin G
×
Head & Neck
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled